Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Indexed in:

Web of Science, LILACS, SciELO Brazil, ESCI (Web of Science), Scopus, and PubMed/PMC

Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy

FREQUÊNCIA DOS GENÓTIPOS PARA O POLIMORFISMO I/D DA ECA I EM PESSOAS QUE CONTRAÍRAM COVID-19

ABBD Santos, TF Ribeiro, RB Batista, DD Silva, DP Malerba, FH Borin, CM Ayo, CR Bonin-Domingos

10.1016/j.htct.2023.09.233

Hematol Transfus Cell Ther. 2023;45 Supl 4:S87-8

Full text access

PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH 2 YEARS OF SURVIVAL FOLLOW-UP

NN Shah, PL Zinzani, TA Eyre, K Izutsu, AJ Alencar, K Patel, T Munir, DE Tsai, ML Wang, LYGN Presenter

10.1016/j.htct.2023.09.691

Hematol Transfus Cell Ther. 2023;45 Supl 4:S359-60

Full text access

CARACTERIZAÇÃO DE CÉLULAS MESENQUIMAIS CULTIVADAS NA PRESENÇA DE UMA MOLÉCULA MODULADORA DA EXPRESSÃO DE CICLO-OXIGENASE 2

JPC Rosario, PNM Costa, JM Maçonetto, DGLL Roque, LBMO Chagas, DT Covas, S Kashima

10.1016/j.htct.2023.09.978

Hematol Transfus Cell Ther. 2023;45 Supl 4:S531

Full text access

COINFECÇÃO HIV/SÍFILIS EM DOADORES DE SANGUE DURANTE A PANDEMIA DO CORONAVÍRUS (SARS-COV-2)

RRO Junior, MAE Crispim

10.1016/j.htct.2023.09.1278

Hematol Transfus Cell Ther. 2023;45 Supl 4:S703-4

Full text access

A PHASE 3, TWO-STAGE, RANDOMIZED STUDY OF MEZIGDOMIDE, CARFILZOMIB, AND DEXAMETHASONE (MEZIKD) VERSUS CARFILZOMIB AND DEXAMETHASONE (KD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): SUCCESSOR-2

PGR Md, MA Phd, JRB Md, CCM Phd, MAD Md, CTH Md, JKM Phd, AOM Phd, RZOM Phd, Md HQ, MSR Md, ARM Phd, DW Md, ZZ Phd, VHM Phd, JKM Phd

10.1016/j.htct.2023.09.801

Hematol Transfus Cell Ther. 2023;45 Supl 4:S426-7

Full text access

AVALIAÇÃO DA RESPOSTA SOROLÓGICA ENTRE CINCO DIFERENTES TIPOS DE VACINA CONTRA COVID-19 EM PACIENTES COM LMC - ESTUDO DE VIDA REAL

ACM Toreli, M Miranda-Galvis, M Addas-Carvalho, E Miranda, L Fechio, AS Duarte, A Basso, G Duarte, S Medina, F Pericole, B Benites, R Kolhe, K Jones, H Singh, STO Saad, CA Souza, JE Cortes, K Pagnano

10.1016/j.htct.2023.09.802

Hematol Transfus Cell Ther. 2023;45 Supl 4:S427-8

Full text access